Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Hookipa Pharma IncHOOK-1.000.910.450.49-48.99%9.86%39.78$4.06-$1.611,585$3.78

Detail of Hookipa Pharma Inc

 
CEO
Dr. Malte Peters M.D.
Employees
151
Industry
Biotechnology
Sector
Healthcare
Market cap
$47M

Company details

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-200 for the treatment of pembrolizumab which is in Phase 2 of clinical trial; HB-700, a preclinical development for treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers. Its lead product candidates are HB-400 for the treatment of Hepatitis B which is in Phase I of clinical trial and HB-500 for the treatment of HIV which is in Phase I of clinical trial. The company's preclinical stage products include HB-300 program for prostate cancer. It has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.

Revenue
Revenue (Rev)
$52.16M
Hookipa Pharma Inc
HOOK • XNGS • US
$3.78
+3.37 (796.40%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$3.79
Margin profit
-93.16%
52 week low
$0.4399
52 week high
$6.60
50-day simple moving average
$3.99
200-day simple moving average
$4.06
Percent held by insiders
21.44%
Percent held by institutions
36.53%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
HOOK +722.13%
eps change
HOOK 0.00%